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Fan MHM, Wong KL, Wu S, Leung WK, Yam WC, Wong TM. Pre-conditioning with 
Porphyromonas gingivalis lipopolysaccharide may confer cardio-protection and improve 
recovery of the electrically induced intracellular calcium transient during ischemia and 
reperfusion. J Periodont Res 
 
Background and Objectives: Sublethal doses of Escherichia coli lipopolysaccharide (LPS) 
induce cardio-protection against ischemic insults. This study investigated if Porphyromonas 
gingivalis LPS might give rise to similar effects. We hypothesized that 1) pre-treatment with P. 
gingivalis LPS at appropriate concentrations would induce cardio-protection against injury 
induced by ischemia and reperfusion; and 2) P. gingivalis LPS pre-treatment at 
cardio-protective concentrations may reduce Ca
2+
 overload—a precipitating cause of 
injury—and improve recovery of contractile function. 
Material and Methods: Male Sprague-Dawley rats were randomly given intra-peritoneal saline 
or hot phenol/water-extracted P. gingivalis LPS at 0.2, 0.5, 1.0, 2.0. or 4.0 mg/kg 24 h before 
experiment. The hearts were isolated and subjected to regional ischemia by coronary artery 
ligation followed by reperfusion. In isolated rat ventricular myocytes, the cytosolic Ca
2+
 level 
and the electrically induced intracellular calcium (E[Ca
2+
]i) transient, which reflects contractile 
function, were determined after pre-treatment with a cardio-protective dose of P. gingivalis 
LPS.  
Results: Pre-treatment with 0.5 mg/kg P. gingivalis LPS significantly reduced, while 
pre-treatment with 1.0 to 4.0 mg/kg significantly increased infarct size. The Ca
2+
 overload 
induced by ischemia/reperfusion was attenuated in myocytes from rats pre-treated with 0.5 
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mg/kg P. gingivalis LPS. Treated myocytes also showed an increased amplitude of the E[Ca
2+
]i 
transient, abolished prolongation of the time to reach the peak E[Ca
2+
]i transient, and shorter 
50% decay time during reperfusion following LPS pre-treatment. 
Conclusion: 0.5 mg/kg P. gingivalis LPS confers cardio-protection against 
ischemia/reperfusion-induced injury and improved intracellular E[Ca
2+
]i transient recovery, 
hence improving myocyte contractile recovery. 
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Porphyromonas gingivalis is a gram-negative anaerobic bacillus and one of the 500 different 
species of naturally occurring bacteria in the oral cavity. The bacterium, a known 
periodontopathogen, has been reported to be involved in cardiovascular diseases in subjects 
with periodontitis (1, 2). Proposed mechanisms include systemic release of antigen like P. 
gingivalis lipopolysaccharide (LPS) or endotoxin from infected periodontal pockets (3), or local 
persistent inflammation leading to modulation of systemic cytokine levels (4) and/or ability of 
the bacterium to invade endothelial cells (5) and blood vessels rendering bacteremia (6). The 
LPS of P. gingivalis is also known to be associated with the development of periodontal diseases 
(7) and has also been postulated to be a predisposing factor for atherosclerotic diseases (8).  
Phenol/water-extracted P. gingivalis LPS is the ligand for cell surface toll-like receptors (TLR), 
TLR2 and TLR4 (9), and stimulation of either TLR2 or TLR4 can result in activation of 
phosphoinositide-3-kinase/Akt-dependent signaling (10), which has been shown to protect 
myocytes from ischemic reperfusion injury (11). We hypothesized that pre-treatment with P. 
gingivalis LPS at appropriate concentrations would induce cardio-protection against injury 
induced by ischemia and reperfusion.  
 Ca
2+
 homeostasis is essential to contractile function of the heart and protection against 
cardiac injury. When an action potential arrives, the sarcolemmal membrane of cardiac myocyte 
is depolarized. Depolarization of the sarcolemmal membrane opens the voltage gated Ca
2+
 
channel, thus allowing the entry of Ca
2+
 into the myocyte. The Ca
2+
 triggers a massive amount 
of Ca
2+
 released via the ryanodine receptor from the sarcoplasmic reticulum, the intracellular 
Ca
2+
 store. The release of a massive amount of Ca
2+
 in a short time results in a sudden increase 
in cytosolic Ca
2+
, a Ca
2+
 transient, which triggers contraction. After contraction, Ca
2+
 is 
removed from the cytosplasm as a result of sequestration of Ca
2+
 back to the sarcoplasmic 
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reticulum via the Ca
2+
 ATPase and out of the myocyte via the Na
+
-Ca
2+
 exchanger. Removal of 
Ca
2+
 from the cytoplasm results in relaxation (12). Alterations in Ca
2+
 homeostasis may 
therefore lead to alterations in myocyte contractile function and cytosolic Ca
2+
 level. It is well 
established that myocyte cytosolic Ca
2+
 overload is a precipitating factor of cardiac injury. We 
reasoned that if P. gingivalis LPS had cardio-protective effect, it may affect myocyte Ca
2+
 
homeostasis, which may alter its cytosolic Ca
2+
 homeostasis and hence the contractile function. 
In the present study we first attempted to test the hypothesis that sublethal dose of P. 
gingivalis LPS pre-treatment may protect the heart against ischemic insult. We studied the 
effects of hot phenol-water extracted P. gingivalis LPS on infarct size of the rat heart subjected 
to ischemia and reperfusion using the Langendorff isolated perfused heart preparation. In the 
second series of experiments we attempted to test the hypothesis that P. gingivalis LPS 
pre-treatment at cardio-protective concentrations may alter myocyte Ca
2+
 homeostasis, 
particularly reducing Ca
2+
 overload, hence improving myocytes contractile recovery upon 
ischemic insult. We determined the effects of P. gingivalis LPS at a concentration, that was 
shown to reduce the infarct size inducible by ischemic insult in the first series of experiment, on 
cytosolic Ca
2+
 level and the electrically induced intracellular Ca
2+
 (E[Ca
2+
]i) transient in single 
ventricular myocyte according to a procedure routinely used in our laboratory.  
 
 
Materials and Methods 
 
Study design 
To test the first hypothesis the effects of 24 h pretreatment with hot phenol-water extracted P. 
Page 6 of 34
Journal of Periodontal Research
Journal of Periodontal Research - manuscript proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Manuscript proof
 7 
gingivalis LPS 0.2 - 4 mg/kg body weight on the infarct size of isolated rat heart induced by 
ischemia/reperfusion were determined. Then the effects of the endotoxin preparation at 
concentration shown in the first series of experiment that could reduce the infarct size induced 
by ischemia/reperfusion, on isolated rat myocyte cytosolic Ca
2+
 level and the E[Ca
2+
]i transient 
were followed. The E[Ca
2+
]i transient is elicited by an electrical stimulation, which mimicks the 
arrival of an action potential. An electrical stimulation or action potential depolarizes the 
sarcolemmal membrane, which opens up the voltage gated L-type Ca
2+
 channel, leading to an 
influx of Ca
2+
 into the cytoplasm. The Ca
2+
 in turn triggers the release of Ca
2+
 from the 
intracellular Ca
2+
 store, the sarcoplasmic reticulum, leading to a sudden increase in [Ca
2+
]i. So 
the amount, the amplitude, and the rate, time to peak, of Ca
2+
 released determine the 
contractility. The decay, 50% decay, reflects the removal of Ca
2+
 from the cytosol and 
determines relaxation. A previous study from our lab showed that the amplitude of the transient 
is directly correlated to the shortening of the isolated ventricular myocyte (13). 
 
Preparation of P. gingivalis LPS 
The hot phenol-water extraction method (14) was adopted to prepare P. gingivalis LPS. P. 
gingivalis type strain ATCC 33277 was anaerobically cultured in tryptic soy broth supplemented 
with 1 mg/mL yeast extract, 5 µg/mL of hemin, and 1 µg/mL menadione. At mid-log phase 
growth (OD at 660 nm = 0.35), the bacteria were harvested by centrifugation (10,000 × g), and 
washed twice in phosphate buffered saline. One gram of cells was suspended in 17.5 mL of 
water, boiled for 30 min, and disrupted by ultrasonication on ice; 15 mL of this suspension was 
then mixed with 15 mL of a 50% (v/v) solution of phenol (in the form of 90% phenol crystals) 
and double-distilled water pre-warmed to 68°C. The mixture was incubated at 68°C with 
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vigorous shaking for 20 min, incubated in an ice bath for 15 min, and centrifuged at 1,500 × g 
for 45 min at 10°C. The upper aqueous layer containing the LPS was transferred to a new tube 
on ice, while 15 mL of distilled water at 68°C was added to the phenol layer and the extraction 
process repeated. The pooled aqueous solution was centrifuged at 12,000 × g, 4°C for 10 min 
and the supernatant was dialyzed against double-distilled water at 4
o
C for 3 to 5 days. The 
dialyzed solution was then centrifuged at 146,600 × g, 4°C for 4 h. The pellet was washed twice 
with double-distilled water and centrifuged again, and was finally resuspended in 
double-distilled water and frozen at -70
o
C overnight by lyophilization. Every gram wet weight 
of P. gingivalis yielded 61.7 µg of LPS or every P. gingivalis bacterium yield 0.037 pg of dry 
LPS. 
A protein assay was performed to confirm the purity of the extracted LPS, and no 
detectable protein was found in the sample. DNA content of the extracted LPS was analyzed by 
PCR using P. gingivalis specific (15) or universal 16S rDNA primers (16). Detection limits of 
both protocols were ≥ 0.00001% or 0.0001% of DNA by weight, respectively. No P. gingivalis 
DNA nor any bacterial 16S rDNA was detectable. Lipid A was extracted from the LPS as 
described previously (17) and subjected to matrix-assisted laser desorption ionization-time of 
flight mass spectrometry analysis at the Genome Research Centre, The University of Hong 
Kong. The species of lipid A in the preparation was identified as P. gingivalis triacylated lipid A, 
as described in the literature (18). No attempt was made to characterize the level of 
contaminating cell surface polysaccharides in the preparation. 
 
Animal experiments 
The study was approved by the Committee on the Use of Live Animals in Teaching and 
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Research, The University of Hong Kong. Two series of experiments were performed. The first 
studied the impact of pre-treating rats with different concentrations of P. gingivalis LPS on 
infarct size induced by ischemia and reperfusion in the isolated perfused rat heart (Fig. 1A). The 
second series of experiments studied the effects of a pre-conditioning cardio-protective dose of 
P. gingivalis LPS on the resting cytosolic [Ca
2+
]i and the electrically induced intracellular Ca
2+
 
(E[Ca
2+
]i) transients in isolated rat ventricular myocyte (Fig. 1B). 
 
P. gingivalis LPS pre-tre tment and rat heart ischemia/reperfusion 
Thirty-six male Sprague-Dawley rats, each about 250 g, were obtained from the Laboratory 
Animal Unit, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and were 
randomly divided into control (n = 7) and test groups. The test group was further divided into 
five subgroups that were given an intra-peritoneal injection of 0.2, 0.5, 1.0, 2.0, or 4.0 mg/kg 
body weight of P. gingivalis LPS in 2 mL normal saline (n = 8, 6, 4, 4, 7, respectively). These 
doses of P. gingivalis LPS were chosen according to earlier publications regarding 
cardio-protective effects of Escherichia coli LPS (19, 20). The control group was injected with 
2 mL normal saline only.  
Twenty-four hours after the injections, all rats were anesthetized with intra-peritoneal 60 
mg/kg sodium pentobarbitone and then injected with 200 IU of heparin intravenously. Hearts 
were excised rapidly and placed in ice-cold Krebs-Henseleit perfusion buffer (11 mM glucose, 
118 mM NaCl, 4.7 mM KCl, 1.25 mM CaCl2, 1.2 mM MgSO4, 25 mM NaHCO3, 1.2 mM 
KH2PO4) before being mounted on a Langendorff apparatus for perfusion at 37°C with 
perfusion buffer at a constant pressure (100 cm H2O) and equilibrated with 95% O2 and 5% CO2. 
The hearts were allowed to stabilize for 30 min and then subjected to regional ischemia and 
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reperfusion as described previously (21). Any hearts exhibiting arrhythmia during stabilization 
were discarded. A 3-O silk suture was placed around the left anterior descending coronary artery 
from the area immediately below the left atrial appendage to the right portion of the left 
ventricle. The ends of the suture were threaded through a propylene tube to form a snare. The 
left anterior descending coronary artery was occluded by pulling the ends of the suture taut and 
using a hemostat to clamp the snare onto the pericardial surface for 30 min. Ischemia was 
verified by regional cyanosis and a substantial decrease in coronary flow. Reperfusion was 
achieved by releasing the ligature and the heart was reperfused for 120 min to induce 
myocardial injury (21).  
After the reperfusion, the ligature was re-tightened and approximately 0.2 mL of 2.5% 
Evans blue dye (Sigma Chemical, St. Louis, MO, USA) was infused into the heart through the 
jugular vein to stain any permeable tissue, leaving non-perfused vascular (occluded and at risk 
of infarction) tissue uncolored. Excess dye was washed off, and the hearts were frozen and 
sectioned into slices of 3 to 4 mm and then incubated with sodium phosphate buffer containing 
1% 2,3,5-triphenyl-tetrazolium chloride (TTC) (Sigma Chemical, St. Louis, MO, USA) for 15 
min at 37°C to visualize the unstained infarcted region. The infarct size (IS, TTC-negative), the 
area at risk (AAR, TTC-positive) and the size of the left ventricular zone (LV) were determined 
by planimetry with the software Image J from the National Institutes of Health. The percentage 
of AAR/LV formed the AAR% while the percentage of IS/AAR formed the IS%. 
 
Electrically induced intracellular Ca
2+ 
(E[Ca
2+
]i) transient  
In the second series of experiments, 12 male Sprague-Dawley rats, each about 250 g, were 
randomly divided into control and test groups. The test group underwent LPS pre-conditioning 
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by receiving an intra-peritoneal 0.5 mg/kg dose of P. gingivalis LPS dissolved in 2 mL saline 24 
h before the experiment, whereas the control group received the saline injection only. This dose 
was chosen as it was shown to confer a cardio-protective effect to ischemia/reperfusion insults 
in the isolated heart in the first series of experiments.  
Twenty-four hours after the injection, the rats were anesthetized with intra-peritoneal 60 
mg/kg sodium pentobarbitone and decapitated. Ventricular myocytes were then isolated from 
the hearts of the rats using the collagenase method as described previously (22). The heart was 
mounted on an apparatus that allowed retrograde perfusion through the aorta with 0.2% 
collagenase and 0.03% protease dissolved in Tyrode’s solution (5 mM glucose, 143 mM NaCl, 
5.4 mM KCl, 0.5 mM MgCl2, 0.3 mM NaH2PO4, 5 mM HEPES) which passed through a water 
bath at 37
o
C. After 30 min of digestion, the heart was removed from the apparatus and the 
ventricle of the heart was cut into pieces in Tyrode’s solution and then homogenized by 
pipetting. The cell suspension was filtered through a mesh screen and the cells were suspended 
in 20 mL Tyrode’s solution at room temperature, with CaCl2 solution gradually added to bring 
the Ca
2+ 
concentration to 1.25 mM over 30 min. The cells were stabilized for 30 min at room 
temperature and the viability of the myocytes was confirmed using light microscopy.  
E[Ca
2+
]i transients were measured spectrofluorometrically with fura-2 as the Ca
2+ 
indicator. 
The isolated ventricular myocytes were incubated in the dark for 30 min with fura-2 in Krebs 
solution (11 mM glucose, 118 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1.2 mM MgSO4, 25 mM 
NaHCO3, 1.2 mM KH2PO4). The suspension was centrifuged and the cells were washed three 
times with Krebs solution and then resuspended in Krebs solution. A few droplets of the 
myocyte suspension were added to the chamber on the stage of a microscope (Axiobert S100, 
Carl Zeiss, Germany), which was connected to a dual-wavelength excitation spectrofluorometer 
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(Photon Technology International, Princeton, New Jersey, USA). The fluorescence intensities at 
340 nm and 380 nm reflect the equilibrium between Ca
2+
-bound and Ca
2+
-free fura-2 dye, 
respectively, and the ratio is a useful indicator of the cytosolic [Ca
2+
]i of an isolated myocyte 
(23).  
The microscope chamber had a continuous flow of Krebs solution through an inlet tube and 
outlet tube connected to a pump, as well as a direct-current electrode that was connected to an 
electrical stimulation generator that fired every 5 sec (0.2 Hz) to stimulate an action potential. 
To measure the E[Ca
2+
]i
 
transient, we selected rod-shaped myocytes with clear striation and 
showing a regular, clear rhythm of amplitude during spontaneously beating. We subjected the 
cells to 600 sec of metabolic inhibition and anoxia (to simulate ischemic conditions) by infusing 
the chamber with a glucose-free Krebs solution containing 10 mM 2-deoxy-D-glucose and 10 
mM sodium dithionite to capture the glucose and oxygen, respectively. The cells then received 
1300 sec of reperfusion with normal Krebs solution. The ratio of the change in fluorescence 
intensities at the two wavelengths were captured by a monitor device and the data were stored 
for analysis.  
The resting Ca
2+ 
([Ca
2+
]i), and the amplitude, time to peak, and T50 (50% decay time) of the 
E[Ca
2+
]i transient were determined. The amplitude and the time to peak represent the amount of 
Ca
2+
 and rate of Ca
2+
 released from the sarcoplasmic reticulum on electrical stimulation, 
respectively. The T50 indicates the rate of removal of Ca
2+
 from the cytosol. 
 
Statistical analyses 
Data were expressed as mean ± standard error of the mean (SEM). Statistical comparisons of the 
infarct size were performed by one-way analysis of variance followed by Tukey’s multiple 
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comparison tests. The Student t test was used to determine the difference between test and 
control groups for the results obtained from Ca
2+
 transient measurements. The measurements 
from myocytes of the same rat were averaged and regarded as one sample. A P value of less than 
0.05 indicated a statistically significant difference.  
 
 
Results 
 
Effects of P. gingivalis LPS pre-conditioning on myocardial injury 
Myocardial infarction was induced in all the rat hearts in which the coronary artery had been 
occluded. Pre-treatment with low doses of P. gingivalis LPS resulted in reductions in infarct size 
and the reduction induced by 0.5 mg/kg P. gingivalis LPS was statistically significant. In 
contrast, pre-conditioning with P. gingivalis LPS at higher doses increased the infarct size 
significantly (Fig. 2).  
 
Effects of P. gingivalis LPS pre-conditioning on rat ventricular myocytes  
Because 24-h pre-conditioning with 0.5 mg/kg P. gingivalis LPS conferred cardio-protection 
against injury induced by ischemia and reperfusion, we determined the effects of this 
pre-conditioning protocol on the resting [Ca
2+
]i and its transient, which reflects Ca
2+
 handling 
and contractile functions (Fig. 3). In brief, the control myocyte showed a greater reduction in 
amplitude in E[Ca
2+
]i transient than myocyte from 0.5 mg/kg P. gingivalis LPS treated rat 
during ischemia and at the end of reperfusion. In myocytes of the control animals, the resting 
[Ca
2+
]i was significantly elevated during ischemia and further elevated during reperfusion (Fig. 
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4). In myocytes of the treatment group, the resting [Ca
2+
]i was significantly elevated during 
ischemia but remained at the same level during reperfusion; the levels during both ischemia and 
reperfusion were lower than those in the controls but only the difference during reperfusion was 
statistically significant.  
In general, the amplitude of the E[Ca
2+
]i transient, which represents the amount of Ca
2+ 
released from the sarcoplasmic reticulum, markedly decreased during ischemia and recovered 
partially during reperfusion (Figs. 3 and 5). In the sample of myocytes from rats treated with 0.5 
mg/kg P. gingivalis LPS, the reduction in the amplitude of the E[Ca
2+
]i transient during the 
ischemic period was significantly less than in the controls, whereas the recovery in amplitude 
during reperfusion was significantly greater than in the controls.  
The time to reach the peak of the E[Ca
2+
]i transient, which reflects the speed of Ca
2+
 
release from the sarcoplasmic reticulum, was significantly prolonged during reperfusion in the 
control group (Figs. 3 and 6). The prolongation was abolished in the treatment group. 
The T50 of the E[Ca
2+
]i transient, which reflects the speed of removal of Ca
2+
 from the 
cytosol, increased significantly during ischemia and recovered partially during reperfusion in 
the control group (Figs. 3 and 7). The corresponding value in the treatment group during 
ischemia was significantly lower than that in the control group. 
 
 
Discussion 
There are two main novel findings in the present study. The first one is that pre-treatment by P. 
gingivalis LPS produced biphasic effects on ischemia/reperfusion-induced injury in the rat heart. 
At the dose of 0.5 mg/kg administered intra-peritoneally, P. gingivalis LPS is beneficial against 
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ischemia/reperfusion induced injury. At a higher dose range, however, it exacerbates the injury 
induced by ischemia/reperfusion as has been observed in other gram-negative bacterial 
endotoxin like E. coli LPS (19, 24). The second novel finding is that at the dose of 0.5 mg/kg, 
which was shown to confer cardio-protection, P. gingivalis LPS attenuates the cytosoclic Ca
2+
 
overload, in agreement with its cardio-protective action, and more importantly it improves the 
recovery of E[Ca
2+
]i transient, which reflects the contractile function. Similar to the current 
study, reports showed sublethal doses of E. coli LPS up to 10 mg/kg protect the rat heart against 
injury induced by ischemia/reperfusion (19, 25). The beneficial effects of LPS of P. gingivalis 
and E. coli support the notion that the endotoxins may prevent infections and damage caused by 
ischemia/reperfusion (26). 
We found for the first time that pre-conditioning with 0.5 mg/kg P. gingivalis LPS 
increased the amplitude and speed of the ising phase and the speed of recovery to the resting 
level of the E[Ca
2+
]i transient, indicating greater Ca
2+
 release at a faster rate and more efficient 
removal of Ca
2+
 from the cytosol after contraction. These events in turn would increase the 
contractility and speed up relaxation of myocytes. Hence, the LPS at a dose that confers 
cardio-protection also improves contractile recovery after ischemic insult. 
E. coli and P. gingivalis are two different families of the naturally occurring bacteria in the 
gastrointestinal tract. It is well documented their LPSs possess different biochemical properties 
and interact selectively on different subtypes of TLRs (27). It is of interest to note that P. 
gingivalis LPS at the dose of 0.5 mg/kg is beneficial whereas E. coli LPS up to 10 mg/kg 
protects the rat heart against injury induced by ischemia/reperfusion (19, 25). The different 
doses of LPS from two different bacteria that confer cardio-protection may be explained partly 
by the possible different mechanisms.  
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Cardio-protection induced by bacterial endotoxins has been linked to the activation of TLR 
transmembrane receptors (11). The receptors TLR 2, 3, 4, and 6 are expressed on myocytes (28), 
and LPSs are known to recognize and bind to TLR2 and TLR4 to elicit cellular responses (29, 
30). Phenol/water-extracted P. gingivalis LPS is the ligand for TLR2 and TLR4 (9), whereas the 
pure form of the LPS from E. coli is the ligand for TLR4 only (9, 31). Stimulation of either 
TLR2 or TLR4 can result in activation of phosphoinositide-3-kinase/Akt-dependent signaling 
(10), which has been shown to protect myocytes from ischemic reperfusion injury (11). TLR2 is 
believed to be cardio-protective against oxidative stress in neonatal rat cardiac myocytes (28). 
The relative contributions of TLR2 or TLR4 in the host response to P. gingivalis LPS challenge 
are yet to be characterized.  
P. gingivalis LPS pre-treatment was administered intra-peritoneally to test animals—an 
established and convenient administration method. Abdulla and co-workers (32) previously 
reported on the bioavailability of E. coli LPS after intra-peritoneal administration. In brief, the 
rat serum endotoxin concentration peaked at 6 h to a level of 10 ng/mL after intra-peritoneal 
injection of 25 µg of E. coli LPS, meaning that 0.4% of what was administered entered the 
systemic circulation. These observations are explained by hepatic first-pass and liver clearance 
of LPS (33), in which combined actions of Kupffer cells, CD14, and LPS-binding proteins 
result in highly effective detoxification of the administered LPS (34, 35). We estimate that a 
peak level of 10 to 50 ng/mL of P. gingivalis LPS might be available to the rat systemic 
circulation approximately 6 h after 0.5 mg/kg LPS intra-peritoneal administration. That amount 
of LPS administered was estimated to be equivalent to endotoxin extractable from 2.7×10
9
 
bacterial cells or 27 ml of mid-log phase P. gingivalis culture. Further studies are however 
warranted to quantify the postulated LPS bioavailability. The postulated systemic circulatory 
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exposure to LPS from periodontopathogens, nevertheless would be highly probable in human 
with advanced periodontitis in which P. gingivalis LPS directly enters the systemic circulation 
through inflamed ulcerated periodontal pockets (36). 
Although this study was performed in rats to closely related models, extrapolation of the 
deleterious effects of P. gingivalis LPS in periodontitis, such as affecting systemic or cardiac 
health, clinical settings for humans should be made with caution. Furthermore, we used 
phenol/water-extracted P. gingivalis LPS, so further research to study the effects of 
column-purified P. gingivalis LPS on heart tissue as well as the possible mechanisms of 
host-LPS interactions are needed.  
The delayed nature of protection suggests that cardio-protective proteins may be 
synthesized de novo. Three classes of proteins are known to be end-effectors responsible for 
delayed cardio-protection after pre-conditioning: heat-shock protein families (37-39); 
intracellular antioxidant enzymes, including catalase (19) and superoxide dismutase (40, 41); 
and inducible nitric oxide synthase (42, 43). P. gingivalis LPS has been shown to be able to 
enhance expression of the cardio-protective superoxide dismutase in human monocytic cell 
lines (44). Further study on the contribution of this protein to the cardio-protective action of P. 
gingivalis LPS is warranted. 
Paradoxically, when the dose of P. gingivalis LPS increased to between 1 and 4 mg/kg, 
myocardial injury was exacerbated and the infarct size increase significantly. Similarly, 
high-dose E. coli LPS, in contrast to a low dose, can induce TLR4-mediated NF-κB activation, 
trigger transcription of inflammatory mediators (45), and induce cardiac dysfunction (46, 47). 
The same phenomena might be in action during challenge with a higher dose of P. gingivalis 
LPS.  
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Conclusion 
We demonstrate for the first time that phenol/water-extracted P. gingivalis LPS given 
intra-peritoneally has biphasic effects on cardiac injury induced by ischemia/reperfusion in the 
rat heart 24 h after its administration. A sublethal intra-peritoneal dose (0.5 mg/kg) of P. 
gingivalis LPS can reduce the infarct size and [Ca
2+
]i overload induced by ischemia and 
reperfusion, indicating a delayed cardio-protective action. In addition, the same dose of P. 
gingivalis LPS improves recovery of the electrically induced [Ca
2+
]i transient, suggesting that 
LPS may improve contractile recovery. Further experiments are warranted to clarify the exact 
nature of such bacterial-host cardiac interactions. 
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Legends 
 
Fig. 1. Experimental protocol. A. Infarct size experiment. Rats were treated intra-peritoneally 
either with normal saline, or 0.2, 0.5, 1.0, 2.0, or 4.0 mg/kg of P. gingivalis LPS. 24 hours later, 
hearts were harvested, mounted on a Langendorff apparatus, stabilized for 30 min, and 
subjected to 30 min regional ischemia followed by 120 min reperfusion; then the infarct size 
was measured. B. Ca
2+ 
transient experiment. Rats were treated intra-peritoneally with 0.5 
mg/kg of P. gingivalis LPS. 24 hours later, hearts were harvested and myocytes were isolated for 
Ca
2+ 
transient measurement with spectrofluorometric method using fura-2 as the Ca
2+ 
indicator. 
Myocytes were stabilized for 30 min before being subjected to 10 min of metabolic inhibition 
and anoxia (MI/A) with 10 mM 2-deoxy-D-glucose and 10 mM sodium dithionite in 
glucose-free Krebs solution, followed by 20-min reperfusion.  
 
Fig. 2. Effects of P. gingivalis LPS pre-conditioning on ischemia/reperfusion-induced 
myocardial injury. Rats were pre-conditioned with 24-h saline (control), or 0.2, 0.5, 1.0, 2.0, or 
4.0 mg/kg of intra-peritoneally administrated P. gingivalis LPS. Isolated perfused rat hearts 
were subjected to ischemia and reperfusion, and infarct size was determined at the end of 
reperfusion, expressed as a percentage of the area at risk. Values are mean ± SEM. Control, n = 
7; 0.2 mg/kg, n = 8; 0.5 mg/kg, n = 6; 1.0 mg/kg, n = 4; 2.0 mg/kg, n = 4; 4.0 mg/kg, n = 7. ** P 
< 0.01 vs. Control; ### P < 0.001 vs. 0.5 mg/kg P. gingivalis LPS group. 
 
Fig. 3. Tracings of the electrically induced intracellular Ca
2+
 (E[Ca
2+
]i) transients in rat 
ventricular myocytes. The Ca
2+
 transients from the control and test groups 24 hour after 
intra-peritoneal administration of 0.5 mg/kg of P. gingivalis LPS were compared before (stable) 
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and during ischemia (metabolic inhibition and anoxia; MI/A), and at the end of reperfusion. 
Note the reduction in amplitude in control group, and to a lesser extent in the test group, during 
ischemia and at the end of reperfusion. Loss of rhythm can also be observed in the control group 
during ischemia. 
 
Fig. 4. Effects of 24-h pre-conditioning with 0.5 mg/kg of P. gingivalis LPS on resting [Ca
2+
]i 
level in rat ventricular myocytes. Values are expressed as mean ± SEM, n = 6. * P < 0.05, ** P < 
0.01, and *** P < 0.001 vs. stable period within the group; ◊◊ P < 0.01 vs. corresponding 
control [Ca
2+
]i during reperfusion. (MI/A = metabolic inhibition and anoxia.) 
 
Fig. 5. Effects of 24-h preconditioning with 0.5 mg/kg of P. gingivalis LPS on amplitude of 
E[Ca
2+
]i of rat ventricular myocytes. Values are expressed as mean ± SEM, n = 6. *** P < 0.001 
vs. stable period within the group; ### P < 0.001 vs. period of metabolic inhibition and anoxia 
(MI/A) within the group; ◊ P < 0.05, ◊◊◊ P < 0.001 vs. corresponding control value during the 
reperfusion and MI/A period, respectively.  
 
Fig. 6. Effects of 24-h preconditioning with 0.5 mg/kg of P. gingivalis LPS on time to peak of 
E[Ca
2+
]i in rat ventricular myocytes. Values are expressed as mean ± SEM, n = 6. * P < 0.05 vs. 
stable period within the group; ◊ P < 0.05 vs. the corresponding control value during metabolic 
inhibition and anoxia (MI/A) or reperfusion period. 
 
Fig. 7. Effects of 24-h preconditioning with 0.5 mg/kg of P. gingivalis LPS on T50 (50% decay 
time) of E[Ca
2+
]i transient in rat ventricular myocytes. Values are expressed as mean ± SEM, n = 
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6. * P < 0.05, ** P < 0.01 vs. stable period within the group; # P < 0.05 vs. period of metabolic 
inhibition and anoxia (MI/A) within the group; ◊ P < 0.05 vs. the corresponding control value 
during the MI/A period. 
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